Acumen Pharmaceuticals' Unattributed VC Round

Acumen Pharmaceuticals raised a round of funding on August 21, 2006.

Acumen Pharmaceuticals is engaged in the discovery and development of therapeutics and diagnostics related to soluble Aß oligomers in Alzheimer's disease. Soluble Aß oligomers are now widely recogni…

Articles about Acumen Pharmaceuticals' Unattributed VC Round: